Diagnosis of Fabry Disease
Fabry disease can be diagnosed through a range of laboratory tests. The alpha-GAL enzyme measurement is considered to be the most accurate diagnostic test, although its reliability is higher in males. In certain states, enzyme testing for Fabry disease is already being included in newborn screenings. Genetic testing is also highly valuable, particularly for females, as it can help identify the specific gene mutation that is responsible for causing the disease.
Enzyme Replacement Therapy: A Promising Treatment for Preventing Fatty Buildup
Enzyme replacement therapy (ERT) has emerged as a promising treatment option for individuals seeking to prevent the accumulation of fatty substances in their bodies. Through this treatment, patients receive synthetic replacement enzymes via intravenous infusion, which effectively perform the role of alpha-GAL, the enzyme responsible for breaking down fatty substances. While ERT does not provide a cure, it significantly slows down the buildup of fatty substances, thus preventing or delaying the development of heart and kidney damage.